- Home
- TBLA vs RXST Comparison
TBLA vs RXST Comparison
Compare TBLA & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TBLA
- RXST
- Stock Information
- Founded
- TBLA 2007
- RXST 1997
- Country
- TBLA United States
- RXST United States
- Employees
- TBLA N/A
- RXST N/A
- Industry
- TBLA Computer Software: Programming Data Processing
- RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- TBLA Technology
- RXST Health Care
- Exchange
- TBLA Nasdaq
- RXST Nasdaq
- Market Cap
- TBLA 1.2B
- RXST 1.2B
- IPO Year
- TBLA N/A
- RXST 2021
- Fundamental
- Price
- TBLA $2.84
- RXST $25.10
- Analyst Decision
- TBLA Strong Buy
- RXST Strong Buy
- Analyst Count
- TBLA 5
- RXST 8
- Target Price
- TBLA $5.05
- RXST $51.63
- AVG Volume (30 Days)
- TBLA 2.9M
- RXST 579.9K
- Earning Date
- TBLA 02-26-2025
- RXST 02-25-2025
- Dividend Yield
- TBLA N/A
- RXST N/A
- EPS Growth
- TBLA N/A
- RXST N/A
- EPS
- TBLA N/A
- RXST N/A
- Revenue
- TBLA $1,766,220,000.00
- RXST $139,927,000.00
- Revenue This Year
- TBLA $17.09
- RXST $37.41
- Revenue Next Year
- TBLA $14.31
- RXST $22.86
- P/E Ratio
- TBLA N/A
- RXST N/A
- Revenue Growth
- TBLA 22.68
- RXST 57.09
- 52 Week Low
- TBLA $2.69
- RXST $24.79
- 52 Week High
- TBLA $4.67
- RXST $66.54
- Technical
- Relative Strength Index (RSI)
- TBLA 30.28
- RXST 19.44
- Support Level
- TBLA $2.69
- RXST $26.17
- Resistance Level
- TBLA $3.10
- RXST $29.00
- Average True Range (ATR)
- TBLA 0.21
- RXST 1.32
- MACD
- TBLA -0.08
- RXST -0.35
- Stochastic Oscillator
- TBLA 11.64
- RXST 4.43
About TBLA Taboola.com Ltd.
Taboola.com Ltd is a technology company that powers recommendations across the Open Web with an artificial intelligence-based, algorithmic engine. It partners with websites, devices, and mobile apps, collectively referred to as digital properties, to recommend editorial content and advertisements on the Open Web. Geographically it serves Israel, the United Kingdom, Germany, France, Rest of the world whilst it generates the majority of its revenue from the United States.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The Company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.